RNA-seq
Foundation Medicine, Sumitomo Pharma to Develop CDx for Acute Leukemia Treatment
The companies will use the FoundationOne Heme platform to identify patients with acute leukemia who have a KMT2A rearrangement or NPM1 mutations.
Rhode Island Hospital Wins $1M From CARB-X for Molecular Pneumonia Blood Test
The funding supports proof-of-concept studies of a direct-from-blood PCR test informed by RNA sequencing to detect pneumonia-causing bacteria.
The University of Edinburgh spinout is leveraging an RNA normalization technology and analysis software to detect breast cancer early.
Viome Life Sciences Raises $25M in Series D Financing
The firm said that it plans to use the money to help launch its diagnostics division, expand its testing menu, and hire a chief operating officer.
Foundation Medicine, Merus to Develop CDx for Cancer Drug to Treat Patients With NRG1 Fusions
The companies will use Foundation's RNA sequencing platform to develop a companion diagnostic for Merus' bispecific antibody zenocutuzumab.
Mar 12, 2024
Mar 30, 2023
Feb 24, 2022
May 19, 2021